Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.

Benzer Materyaller

• Connection domain mutations in treatment-experienced patients in the OPTIMA trial.
  Yazar:: Dau, B, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study
  Yazar:: Brown, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study.
  Yazar:: Sheldon T Brown, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-01-01)
• Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.
  Yazar:: Bayoumi, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
  Yazar:: Mocroft, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)